1 – 15 of 38
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Long-Term Outcome of Graves’ Disease : A Gender Perspective
(
- Contribution to journal › Article
-
Mark
Fracture incidence in Graves' disease : A population-based study
(
- Contribution to journal › Article
- 2022
-
Mark
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
(
- Contribution to journal › Article
-
Mark
Long term outcome after toxic nodular goitre
(
- Contribution to journal › Article
-
Mark
Ultraljud värdefullt komplement i utredning av tyreoideasjukdom
(
- Contribution to journal › Article
- 2021
-
Mark
Treatment of patients with Graves’ disease in Sweden compared to international surveys of an ‘index patient’
(
- Contribution to journal › Article
-
Mark
Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients : A 2020 THESIS Questionnaire Survey of Members of the Swedish Endocrine Society
(
- Contribution to journal › Article
-
Mark
Serum CYR61 Levels are Associated with Graves' Ophthalmopathy and Smoking in Patients with Graves' Disease
(
- Contribution to journal › Article
- 2019
-
Mark
Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism : A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey
(
- Contribution to journal › Article
-
Mark
The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease
(
- Contribution to journal › Article
-
Mark
Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
(
- Contribution to journal › Article
-
Mark
Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease
(
- Contribution to journal › Article
-
Mark
Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients
(
- Contribution to journal › Article
- 2018
-
Mark
Study of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population
(
- Contribution to journal › Article
- 2017
-
Mark
Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels
(
- Contribution to journal › Article